Mirum Pharmaceuticals (MIRM) Asset Utilization Ratio (2021 - 2026)

Mirum Pharmaceuticals' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.66 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 17.9% year-over-year to 0.66 in Q1 2026; TTM through Mar 2026 was 0.66, a 17.9% increase from a year earlier, with the FY2025 full-year figure at 0.69, up 34.69% from the prior year.
• Asset Utilization Ratio rose to 0.66 in Q1 2026 per MIRM's latest filing, from 0.64 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.66 in Q1 2026 and bottomed at 0.11 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.34 (2024), against an average of 0.39.
• Across the five-year window, Asset Utilization Ratio jumped 197.44% in 2022 and increased 17.9% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.21 in 2022, then surged by 33.72% to 0.29 in 2023, then soared by 75.17% to 0.5 in 2024, then grew by 27.25% to 0.64 in 2025, then advanced by 2.6% to 0.66 in 2026.
• Per Business Quant, the three latest MIRM Asset Utilization Ratio figures stand at 0.66 (Q1 2026), 0.64 (Q4 2025), and 0.62 (Q3 2025).